£2.1M
The funding round was led by Faber with participation from Ganexa Capital and Innovate UK.

Abtrace uses machine learning and artificial intelligence to transform the detection and treatment of chronic health conditions.
Abtrace builds machine learning software that integrates with electronic health records to help clinicians monitor and treat long term health conditions. The company works alongside the NHS to improve early detection and streamline patient care.
Umar Naeem Ahmad
CEO
The funding round was led by Faber with participation from Ganexa Capital and Innovate UK.